Activation of p53 by Protein Inhibitor of Activated Stat1 (PIAS1)*

The tumor suppressor protein p53 functions as a transcriptional factor that activates genes controlling cell cycle arrest and apoptosis. Here, we report that protein inhibitor of activated Stat1 (PIAS1) interacts with the tetramerization and C-terminal regulatory domains of p53 in yeast two-hybrid analyses. Endogenous PIAS1 is also associated with endogenous p53 in mammalian cells. Ectopic expression of PIAS1 activates p53-mediated expression in mouse embryonic fibroblast cells (p53 −/−) as well as a variety of other cell lines. Furthermore, ectopic expression of PIAS1 induces p53-mediated expression of cyclin-dependent kinase inhibitor p21 and G1arrest of the cell cycle in H1299 cells. In addition, a PIAS1 mutant without the RING-finger domain required for sumoylation could still activate p53-mediated gene expression, indicating that activation of p53 by PIAS1 does not require the RING-finger domain. Taken together, our results suggest that PIAS1 is a novel activator of p53.

[1]  K. Shuai,et al.  Induction of Apoptosis by Protein Inhibitor of Activated Stat1 through c-Jun NH2-terminal Kinase Activation* , 2001, The Journal of Biological Chemistry.

[2]  H. Yasuda,et al.  Involvement of PIAS1 in the sumoylation of tumor suppressor p53. , 2001, Molecular cell.

[3]  C. Prives,et al.  The C-terminus of p53: the more you learn the less you know , 2001, Nature Structural Biology.

[4]  J. Darnell,et al.  A Drosophila PIAS homologue negatively regulates stat92E , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Gross,et al.  Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells , 2001, Oncogene.

[6]  K. Vousden,et al.  Regulation and function of the p53 tumor suppressor protein. , 2001, Current opinion in cell biology.

[7]  G. Karpen,et al.  The Drosophila Su(var)2-10 locus regulates chromosome structure and function and encodes a member of the PIAS protein family. , 2001, Genes & development.

[8]  E. Appella,et al.  Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.

[9]  M. Clarke,et al.  Regulation of p53 localization. , 2001, European journal of biochemistry.

[10]  P. Chène,et al.  The role of tetramerization in p53 function , 2001, Oncogene.

[11]  A. Tyner,et al.  Functional analysis and intracellular localization of p53 modified by SUMO-1 , 2001, Oncogene.

[12]  M. Pincus,et al.  Jun NH2-Terminal Kinase Phosphorylation of p53 on Thr-81 Is Important for p53 Stabilization and Transcriptional Activities in Response to Stress , 2001, Molecular and Cellular Biology.

[13]  A. Yang,et al.  p63 and p73: p53 mimics, menaces and more , 2000, Nature Reviews Molecular Cell Biology.

[14]  M. Kaghad,et al.  Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. , 2000, The Journal of biological chemistry.

[15]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[16]  K. Shuai,et al.  Distinct roles of the NH2- and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in cytokine-induced PIAS1-Stat1 interaction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Dejean,et al.  c-Jun and p53 Activity Is Modulated by SUMO-1 Modification* , 2000, The Journal of Biological Chemistry.

[18]  J. D. Weber,et al.  The ARF/p53 pathway. , 2000, Current opinion in genetics & development.

[19]  A. Hengstermann,et al.  Activation of p53 by conjugation to the ubiquitin‐like protein SUMO‐1 , 1999, The EMBO journal.

[20]  R. Hay,et al.  SUMO‐1 modification activates the transcriptional response of p53 , 1999, The EMBO journal.

[21]  L. Bracco,et al.  MBP1: a novel mutant p53-specific protein partner with oncogenic properties , 1999, Oncogene.

[22]  C. Prives,et al.  The p53 pathway , 1999, The Journal of pathology.

[23]  C. Prives.  Signaling to p53 Breaking the MDM2–p53 Circuit , 1998, Cell.

[24]  A. Yang,et al.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.

[25]  D. Chang,et al.  Inhibition of Stat1-mediated gene activation by PIAS1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Jen,et al.  A new human p53 homologue , 1998, Nature Medicine.

[27]  Hirofumi Tanaka,et al.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 , 1997, FEBS letters.

[28]  R. Brent,et al.  Cells that register logical relationships among proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Valdez,et al.  Cloning and characterization of Gu/RH-II binding protein. , 1997, Biochemical and biophysical research communications.

[30]  Stephen N. Jones,et al.  Regulation of p53 stability by Mdm2 , 1997, Nature.

[31]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[32]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[33]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[34]  J. C. Hines,et al.  Nucleus-encoded histone H1-like proteins are associated with kinetoplast DNA in the trypanosomatid Crithidia fasciculata , 1996, Molecular and cellular biology.

[35]  R. Brent,et al.  Interaction mating reveals binary and ternary connections between Drosophila cell cycle regulators. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Roger Brent,et al.  C dil, a Human Gl and S Phase Protein Phosphatase That Associates with Cdk2 , 2003 .